€
11.88
Change
+0.17 +1.45%
Volume
Volume 1.30m
May 20, 2022, 5:35 p.m.
Quotes are delayed by 20 min
Previous close
€ 11.71
€ 11.88
Change
+0.17 +1.45%
Day low
Day high
€11.74
€12.70

52 week low
52 week high
€9.16
€29.70

Market cap
€1.26B
Average volume
816,623
P/E ratio
N/A
Rev. per Employee
N/A
EPS
N/A
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on VLA
-
Pfizer Stock Drops After Earnings. Guidance Fell Short of Estimates.
- Barron's Online
-
Sanofi CEO Says Vaccine Incumbents Are Set to Win
- Barron's Online
-
Valneva Stock Is Jumping on European Vaccine Supply Deal
- Barron's Online
-
FDA Authorizes Mix-and-Match Boosters
- Barron's Online
-
Valneva Says Its Covid Vaccine Beats AstraZeneca's. Shares Are Surging.
- Barron's Online
-
Vaccine Stocks Slip Fourth Day in a Row. Here's Why.
- Barron's Online
-
The U.K. Canceled a Vaccine Deal. Here's the Fallout for Stocks.
- Barron's Online
-
Valneva shares dive after U.K. ends vaccine supply deal
- Steve Goldstein
-
Valneva Gains in Nasdaq Debut as Rival Vaccine Makers Fall
- Barron's Online
- Loading more headlines...
Other News on VLA
-
Zillow, State Street, Valneva, Upstart: What to Watch in the Stock Market Today
- The Wall Street Journal Interactive Edition
-
Pfizer Goes It Alone to Expand Vaccine Business Beyond Covid-19
- The Wall Street Journal Interactive Edition
-
Novavax, J&J Ink Covid-19 Vaccine Deals With U.K.
- The Wall Street Journal Interactive Edition
-
New Effort for Lyme Disease Vaccine Draws Early Fire
- The Wall Street Journal Interactive Edition
Press Releases on VLA
-
Laminar Growth to be Witnessed by Current Trend Of Clostridium Vaccine Market
- marketresearch.biz
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com